Alvimopan 12 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FG1NM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,260
Award facts
- Contract value 100% obligated
- $44,260.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Alvimopan 12 mg capsule unit dose packages in quantities of 30, with a contract value of $44,260.19. The award was made on November 25, 2025, with an ultimate completion date of November 26, 2025, under a firm fixed-price arrangement with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at approximately $1 billion through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical federal medical procurement vendor through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company's federal contract awards demonstrate its capability to supply a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. Alvimopan, a gastrointestinal motility agent typically used in post-operative care, represents one of many specialized pharmaceutical products the contractor supplies through its federal contracts, which collectively reflect the company's versatility in fulfilling diverse federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FG1NM?
SPE2DR26FG1NM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FG1NM worth?
The government has obligated $44,260 on SPE2DR26FG1NM.
Is contract SPE2DR26FG1NM an order under another contract?
Yes. SPE2DR26FG1NM is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1NM competed?
The extent of competition for SPE2DR26FG1NM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award